BioSource International, Inc. Named to Deloitte's "Technology Fast 50'' Program
"All of us at BioSource are proud to once again have our company named to the Deloitte & Touche Fast 50," said Terrance Bieker, the Company's President and Chief Executive Officer.
Tim Lovoy, Deloitte partner, Technology, Media & Telecommunications practice, stated, "To succeed during prosperous times is one thing; to succeed in adversity is much more challenging, and that's exactly what the Deloitte Technology Fast 50 winners have done. We applaud BioSource International, Inc. for its tremendous accomplishments during economically challenging times and for being one of the elite Fast 50 companies in Los Angeles."
Winners of the 19 regional Technology Fast 50 programs in the United States and Canada are automatically entered in the Deloitte & Touche Technology Fast 500 program, which ranks North America's top 500 fastest growing technology companies. For more information on the Deloitte & Touche Fast 50 or Fast 500 programs, visit www.fast500.com.
About Deloitte & Touche
Deloitte & Touche LLP, one of the nation's leading professional services firms, provides audit, tax financial and advisory services and consulting through nearly 30,000 people in more than 80 U.S. cities. Known as an employer of choice for innovative human resources programs, the firm is dedicated to helping its clients and its people excel. "Deloitte" refers to the associated partnerships of Deloitte & Touche USA LLP (Deloitte and Touche LLP and Deloitte Consulting LLP) and subsidiaries. Deloitte is the US member firm of Deloitte Touche Tohmatsu. For information, please visit Deloitte's web site at www.deloitte.com/us.
About BioSource International, Inc.
BioSource International, Inc. is a broad-based life sciences company focused on providing integrated solutions in the areas of functional genomics, proteomics, and drug discovery through the development, manufacturing, marketing, and distribution of unique, biologically active reagent systems which facilitate, enable, and accelerate pharmaceutical development and biomedical research. For more information, please visit the Company's Web site at www.biosource.com.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.